Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:31:07 EDT Wed 02 Jul 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDNA - MEDICENNA THERAPEUTICS CORP. J - https://www.medicenna.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDNA - T  6.50.86·0.880.50.87+0.022.459.449550.85  0.88  0.822.625  0.7815:55:02Jun 2615 min RT 2¢
TSX - T6.50.86·0.880.50.87+0.022.429.625230.85  0.88  0.822.625  0.7815:55:0215 min
Alpha - A 0.88+0.033.513.01140.85  0.88  0.8513:44:2515 min
Omega - O 0.88+0.033.53.0250.82  0.88  0.8213:24:3415 min
CX2 - H 0.8511.0940.82  0.85  0.8209:43:5315 min
CXD - D 0.850.4010    Jun 3015 min
TriAct - M 0.850.815    Sep 11/2015 min
Lynx - Y 0.851.5110.85  0.85  0.8511:04:3215 min
CS2 - S 0.850.083    Jul 3115 min

Recent Trades - Last 10 of 55
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:55:02T0.870.0250079 CIBC80 National BankK
15:55:00T0.880.0350080 National Bank68 LeedeK
15:52:34T0.880.0350079 CIBC68 LeedeK
15:52:22T0.880.031,5007 TD Sec68 LeedeK
15:52:22T0.880.0350079 CIBC68 LeedeK
13:47:26M0.880.032280 National Bank80 National BankE
13:44:25A0.880.035,0007 TD Sec79 CIBCK
13:24:34O0.880.031,000124 Questrade1 AnonymousK
12:55:08S0.860.01425 Citadel19 DesjardinsE
12:47:17T0.860.0150079 CIBC1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-26 07:00C:MDNA0.91News ReleaseMedicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
2025-06-25 21:11C:MDNA0.91SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-25 21:05C:MDNA0.91SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 21:05C:MDNA0.91SEDAR MD & ASEDAR MD & A
2025-05-02 14:42C:MDNA1.22SEDAR Preliminary Short Form ProspectusSEDAR Preliminary Short Form Prospectus
2025-05-02 10:00C:MDNASEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2025-04-30 18:09C:MDNA1.16News ReleaseMedicenna presents preclinical MDNA113 data at meeting
2025-04-28 19:36C:MDNA1.10News ReleaseMedicenna's MDNA11 showing acceptable safety profile
2025-04-22 07:00C:MDNA1.06News ReleaseMedicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
2025-04-01 07:00C:MDNA0.98News ReleaseMedicenna to Present at Jones Healthcare and Technology Innovation Conference
2025-03-26 15:24C:MDNA0.99News ReleaseMedicenna to present MDNA11 update at AACR
2025-02-25 15:46C:MDNA1.13News ReleaseMedicenna talks MDNA11 Ability-1 study data
2025-02-13 10:28C:MDNA1.27News ReleaseMedicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones
2025-02-12 21:03C:MDNA1.27SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-05 07:00C:MDNA1.26News ReleaseMedicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025
2024-12-13 08:30C:MDNA1.81News ReleaseMedicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast Cancer Symposium (SABCS)
2024-12-05 07:35C:MDNA1.66News ReleaseMedicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA(TM) (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study
2024-11-27 07:00C:MDNA1.77News ReleaseUpdated MDNA11 Monotherapy and Combination Clinical Data from the Ongoing Phase 1/2 ABILITY-1 Study to be Presented at the 2024 Immunotherapy Bridge Conference
2024-11-25 07:30C:MDNA1.57News ReleaseMedicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO)
2024-11-15 07:30C:MDNA1.70News ReleaseMedicenna Reports Second Quarter Fiscal 2025 Financial Results and Corporate Update